MiR-29a represses osteoclast formation and protects against osteoporosis by regulating P300/CBP-associated factor (PCAF)-mediated RANKL and C-X-C motif chemokine ligand 12 (CXCL12) [18]. Here, EP300 is linked to osteoporosis.